Summary by Moomoo AI
Pharmaceutical United Biotechnology Co., Ltd. (WuXi XDC Cayman Inc.) filed an updated Securities Change Month Report with Hong Kong Trading and Settlement Limited on February 5, 2024, reporting stock changes as of January 31, 2024. The report showed that the company's regulated/registered capital reserves remained at 10,000,000,000 shares with a face value of $0.00005 per share for a total of $500,000, with no increase or decrease this month. In addition, under the share option plans prior to the initial public offering in 2021 and 2023, the Company has detailed the grant dates, exercise prices and number of share options for each option plan, but no new shares were issued this month as a result of the exercise of share options. The Company confirms that all securities issuance has been authorised by the Board of Directors and complies with the requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.